Which pharmaceutical product recall in 2004-2005 led to congressional hearings and fundamentally changed how the FDA approaches drug safety monitoring?

Major pharmaceutical product recalls can significantly impact patient safety, company reputation, and market value. These events often lead to enhanced safety protocols and regulatory changes in the medical industry. Test your knowledge about one of the most significant pharmaceutical recalls in recent history that changed how the entire industry approaches product safety and quality control.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Vioxx (rofecoxib) by Merck, withdrawn due to increased risk of heart attacks and strokes
Baycol (cerivastatin) by Bayer, withdrawn due to reports of fatal rhabdomyolysis
Rezulin (troglitazone) by Warner-Lambert, withdrawn due to liver failure risks
Bextra (valdecoxib) by Pfizer, withdrawn due to cardiovascular events and skin reactions